Untreated vitamin D deficiency can lead to disrupted phosphorus-calcium homeostasis, increased risk of metabolic acidosis, hypokalemia, and imbalances in lipid peroxidation processes. This can eventually result in the development of rickets, characterized by skeletal deformities and impaired bone mineralization. These physiological issues underline the necessity for early and effective intervention to prevent long-term complications .

Seasonal variability significantly impacts vitamin D supplementation strategies, as levels naturally increase in summer due to more sun exposure and decrease in winter and early spring. Therefore, supplementation is often adjusted seasonally, with preventive doses prescribed mainly from November to April to counteract reduced natural synthesis. This helps maintain adequate vitamin D levels year-round, preventing deficiencies during periods of low sunlight exposure .

The level of 25-hydroxy-vitamin D is crucial for diagnosing vitamin D deficiency and rickets, as it reflects the body's vitamin D status. In healthy children, it normally ranges from 15 to 40 ng/ml. Seasonal changes affect these levels, increasing to 25-40 ng/ml in summer due to more sun exposure (insolation), and decreasing to 15-25 ng/ml in early spring. A significant drop to 10 ng/ml indicates vitamin D deficiency, and levels below 5 ng/ml correspond to D-beriberi .

The aqueous solution of vitamin D3 is considered more appropriate for treating rickets because it may offer better absorption and is more stable, especially in patients with fat-malabsorption issues. The dosage for both the aqueous and oil solutions is 1 drop containing 500 IU of vitamin D3, but the preferred method often depends on individual patient conditions and the presence of any digestive or metabolic concerns .

Treatment strategies for rickets involve normalizing lipid peroxidation by ensuring adequate doses of vitamin D and proper nutritional support, which help stabilize cell membrane integrity and function. Additionally, correcting metabolic acidosis involves optimizing phosphorus-calcium metabolism through vitamin D and calcium supplementation, which aids in restoring electrolyte balance and normalizing blood pH levels, further contributing to effective overall metabolism management .

Preventive measures, such as administering 200-400 IU of vitamin D from November to April following rickets treatment, contribute to long-term health management by maintaining sufficient vitamin D levels during months with limited sun exposure. This helps prevent recurrence of deficiency and supports overall bone health, ensuring that the processes of phosphorus-calcium homeostasis remain balanced over time .

Rickets has different severity levels, which dictate treatment dosages. For I-th degree severity, a daily dose of 1000-1500 IU of vitamin D is administered for 30 days. II degree severity requires 2000-2500 IU daily for the same duration. III degree severity, or severe cases, require 3000-5000 IU daily for 30 days. After the treatment course, a preventive dose of 200-400 IU is prescribed from November to April for 2-2.5 years .

Different preparations of vitamin D, such as Aquadetrim and Vigantol, are used to address varying metabolic needs in children with rickets by offering flexibility in absorption and patient-specific responsiveness. Aquadetrim, being an aqueous solution, might be more suitable for children with absorption issues, while oil-based Vigantol ensures stable delivery and absorption in children with normal gastrointestinal processing. This tailored approach helps optimize the effectiveness of treatment depending on individual metabolic conditions .

Treatment for rickets focuses on restoring phosphorus-calcium homeostasis, eliminating vitamin D deficiency, normalizing lipid peroxidation, and correcting metabolic acidosis and hypokalemia. This involves ensuring adequate insolation and a balanced diet. Specific treatments include vitamin D therapy alongside calcium supplementation, using various vitamin D medications, such as Aquadetrim (water solution of vitamin D3), Vigantol (vitamin D3 oil solution), and Ergocalciferol (vitamin D2 oil solution). The prescribed dosages vary based on severity, from 1000-1500 IU daily for mild cases to 3000-5000 IU daily for severe cases, followed by a preventive dose of 200-400 IU from November to April for 2-2.5 years .

Insolation, or sunlight exposure, plays a critical role in managing and treating rickets, as it promotes natural vitamin D synthesis in the skin. This interacts with dietary factors since even a properly balanced diet often lacks sufficient vitamin D alone. Hence, ensuring adequate sun exposure complements dietary vitamin D intake, effectively aiding in restoring and maintaining normal vitamin D levels and phosphorus-calcium balance in children .